Decoy 10
Alternative Names: Decoy-10; INDP-010Latest Information Update: 13 Jun 2024
At a glance
- Originator Indaptus Therapeutics
- Class Antineoplastics; Bacteria; Immunotherapies
- Mechanism of Action MPYS protein stimulants; NOD2 protein agonists; Toll-like receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 05 Apr 2024 Pharmacodynamics data from a preclinical trial in Solid tumors presented at the 115th Annual Meeting of the American Association for Cancer Research (AACR-2024)
- 25 Mar 2024 Pharmacodynamics data from a preclinical trial in Solid tumours released by Indaptus Therapeutics
- 19 Apr 2023 Preclinical trials in Solid tumours in USA (IV)